Roux-en-Y Gastric Bypass as a Treatment for Barrett’s Esophagus after Sleeve Gastrectomy
By
Daniel M. Felsenreich
Felix B. Langer
Christoph Bichler
Magdalena Eilenberg
Julia Jedamzik
Ivan Kristo
Natalie Vock
Lisa Gensthaler
Charlotte Rabl
Alexander Todoroff
Gerhard Prager
December 5, 2019
Clinical Scorecard: Roux-en-Y Gastric Bypass for Managing Barrett’s Esophagus Following Sleeve Gastrectomy
At a Glance
Category Detail
Condition Barrett’s Esophagus (BE) developing after Sleeve Gastrectomy (SG) due to reflux
Key Mechanisms Reflux and esophagitis post-SG leading to BE; conversion to Roux-en-Y Gastric Bypass (RYGB) to reduce reflux
Target Population Morbidly obese patients who underwent SG and developed reflux and BE
Care Setting Bariatric surgery centers with endoscopic and functional diagnostic capabilities
Key Highlights
Sleeve gastrectomy is the most common bariatric procedure but may lead to reflux and Barrett’s Esophagus in the long term. Conversion from SG to RYGB is an effective surgical option to treat reflux and potentially manage BE. Comprehensive evaluation including gastroscopy, manometry, and 24 h pH-metry is essential for diagnosis and follow-up.
Guideline-Based Recommendations
Diagnosis
Perform gastroscopy with Seattle protocol biopsies to diagnose BE, requiring intestinal metaplasia and goblet cells. Use manometry and 24 h pH-metry with impedance to assess reflux severity and esophageal function. Evaluate patients with symptomatic reflux after SG for esophagitis and BE.
Management
Initial conservative treatment with lifestyle modifications and proton-pump inhibitors (PPI) for reflux symptoms. Consider conversion from SG to RYGB in patients with persistent reflux and BE. Treat hiatal hernias intraoperatively during RYGB with hiatoplasty as needed.
Monitoring & Follow-up
Conduct gastroscopies before SG, after SG, and after conversion to RYGB to monitor esophageal mucosa. Use symptom questionnaires (GIQLI and BAROS scores) to assess patient-reported outcomes. Follow-up post-RYGB for at least 6 months to evaluate reflux control and BE status.
Risks
Potential persistence or recurrence of reflux symptoms even after RYGB. Risk of esophagitis and progression of BE if reflux is not adequately controlled post-SG. Surgical risks associated with conversion procedures and hiatoplasty.
Patient & Prescribing Data
Morbidly obese female patients post-SG with reflux and Barrett’s Esophagus
Patients initially treated conservatively with PPIs and lifestyle changes but required surgical conversion due to persistent reflux and BE.
Clinical Best Practices
Use a multidisciplinary approach including gastroenterologists and bariatric surgeons for managing BE after SG. Apply the Seattle protocol during endoscopy for accurate diagnosis and surveillance of BE. Perform hiatoplasty during RYGB if hiatal hernia is present to optimize reflux control. Close internal hernia sites during RYGB to reduce postoperative complications. Ensure informed consent and ethical approval for all interventions and studies.
References